Research-led company whose approved medicines, new substances it discovered, in-licensed or acquired, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more. Approved new formulations of approved substances -> HC.PH.PHA.GNX.
- Not here approved products in three or more therapeutic areas → RXB Branded Prescription Drugs